Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of IART will rise by +17.95% over the next 2 Weeks and hit $12.68 by Wednesday, May 6, 2026. In that time frame, IART's share price is expected to range between $12.22 and $13.16.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 6, 2026 | 12.22 | 12.68 | 13.16 |
| May 5, 2026 | 12.13 | 12.54 | 12.96 |
| May 4, 2026 | 11.80 | 12.17 | 12.54 |
| May 1, 2026 | 11.54 | 11.85 | 12.18 |
| Apr 30, 2026 | 11.44 | 11.72 | 12.03 |
| Apr 29, 2026 | 11.42 | 11.69 | 11.98 |
| Apr 28, 2026 | 11.30 | 11.55 | 11.81 |
| Apr 27, 2026 | 10.94 | 11.18 | 11.41 |
| Apr 24, 2026 | 10.63 | 10.86 | 11.09 |
| Apr 23, 2026 | 10.51 | 10.74 | 10.97 |
IART shares fell -4.00% in Thursday, April 23, 2026's trading session, dropping from a previous close of $10.75 to move at $10.32. The stock demonstrated notable intraday movement (see IART's key stats for a full breakdown), fluctuating between $10.11 and $10.86, a +7.47% trading range. While recent weeks have seen some volatility, IART has managed to secure a +7.28% gain over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 802.64K shares changing hands, 255.59K more than the previous session. This amounted to $8.28M in total market activity.
Will IART Continue Its Upward Trend?
According to analyst ratings and projections for IART, Integra LifeSciences Holdings Corporation shares are anticipated to increase by +21.61%, potentially reaching $13.16 per share by May 6, 2026. Short-term technical indicators currently suggest a neutral sentiment for IART. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 18 positive trading days within the past 30 sessions. Based on the IART stock forecast, now is a good time to buy IART stock because its current trading price is -18.61% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on IART covering social and institutional perspectives.
IART Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into IART's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 49.44% to 51.31%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 46.88%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.07%, maintains a neutral outlook for the long term. Insights into IART's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Integra LifeSciences Short-Term Forecasts
IART Forecast For Next 5 Days
Our algorithm anticipates Integra LifeSciences (IART) stock could hit $10.03 by Apr 30, 2026. This represents a -2.81% fall from today's price, following a -8.67% change over the past five days.
IART Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Integra LifeSciences Holdings Corporation (IART) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $10.03, which would mean a -2.81% decrease from the current price of $10.32. Projections for this period range from a high of $11.77 to a low of $8.48.
IART Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Integra LifeSciences's price over the next three months point to a rise. IART stock is expected to peak at $14.25 on Apr 24, 2026 before potentially dipping to $10.10 on Jul 22, 2026. On average, IART is likely to trade around $11.81 in the coming 90 days.
Integra LifeSciences Stock Forecast 2025
Based on our predictive models, Integra LifeSciences (IART) is expected to trade between $2.87 and $14.25 throughout 2026. This would result in an average price of $9.66, potentially offering investors a -6.40% return from current levels.
Integra LifeSciences Holdings Corporation Monthly Forecast 2026–2027
April 2026
According to our latest forecast models, Integra LifeSciences Holdings Corporation (IART) is positioned to show a strong performance in April 2026. The price is predicted to move between $12.39 and $14.25, settling at an average of $13.31. This could translate to a +28.97% gain.
May 2026
Based on current market signals, Integra LifeSciences Holdings Corporation is projected to trend may 2026. We forecast a trading range from $10.42 to $13.32, with a likely average price of $11.51. Investors could expect a potential return of +11.53%.
June 2026
Our predictive algorithms indicate Integra LifeSciences Holdings Corporation stock may see a shift in June 2026. The expected range spans $10.77–$12.84, with an average target of $11.97. This represents a positive outlook and a possible gain of +15.99%.
July 2026
Analyzing established trends, Integra LifeSciences Holdings Corporation looks set to move in July 2026. Projections place the stock between $9.86 and $12.58, averaging around $11.30. This suggests a +9.50% gain from current levels.
August 2026
Market indicators suggest Integra LifeSciences Holdings Corporation could experience notable changes during August 2026. Prices could fluctuate within $8.22 to $11.29, with a midpoint forecast of $10.00. The stock might deliver a -3.10% loss.
September 2026
Forecasting for September 2026, models estimate that Integra LifeSciences Holdings Corporation may undergo key fluctuations. If trends hold, the stock might trade between $5.59 and $9.94, averaging $7.94. This signals a cautious trajectory with potential returns around -23.06%.
October 2026
According to our latest forecast models, Integra LifeSciences Holdings Corporation (IART) is positioned to show a strong performance in October 2026. The price is predicted to move between $5.14 and $7.96, settling at an average of $7.30. This could translate to a -29.26% loss.
November 2026
Based on current market signals, Integra LifeSciences Holdings Corporation is projected to trend november 2026. We forecast a trading range from $4.89 to $9.03, with a likely average price of $8.43. Investors could expect a potential return of -18.31%.
December 2026
Our predictive algorithms indicate Integra LifeSciences Holdings Corporation stock may see a shift in December 2026. The expected range spans $2.87–$8.25, with an average target of $7.92. This represents a cautious outlook and a possible loss of -23.26%.
January 2027
Analyzing established trends, Integra LifeSciences Holdings Corporation looks set to move in January 2027. Projections place the stock between $1.26 and $6.93, averaging around $7.19. This suggests a -30.33% loss from current levels.
February 2027
Market indicators suggest Integra LifeSciences Holdings Corporation could experience notable changes during February 2027. Prices could fluctuate within $0.00 to $5.85, with a midpoint forecast of $6.13. The stock might deliver a -40.60% loss.
March 2027
Forecasting for March 2027, models estimate that Integra LifeSciences Holdings Corporation may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $3.78, averaging $5.00. This signals a cautious trajectory with potential returns around -51.55%.
April 2027
According to our latest forecast models, Integra LifeSciences Holdings Corporation (IART) is positioned to show a strong performance in April 2027. The price is predicted to move between $0.00 and $2.95, settling at an average of $5.36. This could translate to a -48.06% loss.
IART's history of dividends and stock splits also plays a role in long-term investor confidence.

